Mitochondrial regulation and function in cancer and cardiovascular biology
$1,307,705ZIAFY2018HLNIH
National Heart, Lung, And Blood Institute
Investigators
Linked publications & trials
Paper 37579159Paper 37067901Paper 32958587Paper 32472073Paper 31968253Paper 31225506Paper 30774760Paper 30042151Paper 27869650Paper 27003724Paper 25559061Paper 24862268Paper 24101517Paper 23484829Paper 22939227Paper 22841759Paper 22123233Paper 20975668Paper 20919942Paper 19706541Paper 19696408Paper 19617546Paper 19602640Paper 18433754Paper 17551815Paper 16728594Paper 16617118Paper 16614304Paper 16013437Paper 15728378Paper 15682052
Abstract
Our laboratory is interested in the biology of p53 with a focus on its regulation of metabolism and how this can impact cancer and cardiovascular biology. To this end, we are studying Li-Fraumeni syndrome (LFS), an early onset cancer disorder caused by germline mutations in the TP53 gene, using both mouse models and translational studies involving LFS patients. Our investigations to date have yielded insights that may be useful for developing new strategies for preventing cancer and maintaining cardiovascular health. One possibility is the use of metformin for chemoprevention in LFS patients which is being considered as a collaborative project between NIH intramural and extramural investigators.
View original record on NIH RePORTER →